Management ChangeJul 2, 2026, 04:07 PM
CapsoVision Appoints Dr. David S. Shields to Board of Directors
AI Summary
CapsoVision, Inc. announced the appointment of Dr. David S. Shields, a board-certified gastroenterologist with over 40 years of experience, to its Board of Directors, effective July 1, 2026. Dr. Shields has been a clinical advisor to the company for nearly a decade. He succeeds Dr. Joanne C. Imperial, who stepped down from the Board but will continue to support the company as an independent clinical consultant. This appointment comes as CapsoVision approaches key milestones, including the commercial launch of its AI-assisted reading feature for CapsoCam Plus® and the advancement of its CapsoCam Colon™ program.
Key Highlights
- Dr. David S. Shields appointed to CapsoVision's Board of Directors, effective July 1, 2026.
- Dr. Shields is a board-certified gastroenterologist with over 40 years of experience.
- He has served as a clinical advisor and consultant to CapsoVision for nearly a decade.
- Joanne C. Imperial, M.D., stepped down from the Board but remains a clinical consultant.
- CapsoVision anticipates commercial launch of AI-assisted reading for CapsoCam Plus®.
- Company is advancing its second-generation CapsoCam Colon™ program.
- CapsoVision expects expansion of its broader capsule platform.
Price Impact
More from CV